University of British Columbia and Vancouver Coastal Health scientistshave developed a potential cure for a rare eye disease, showing for the firsttime that a drug can repair a birth defect.
They formulated the drug Ataluren into eye drops, and found that it consistently restored normal vision in mice who had aniridia (ANN-uh-ridee-uh), a condition that severely limits the vision of about 5,000 people inNorth America. A small clinical trial with children and teens is expected tobegin next year in Vancouver, the U.S. and the U.K.